Barbara Buckley
Women's Health · Grapevine, TXNPI 1376627042
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.0% of the total across 73 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by AbbVie at 41.4% of the total. Reporting peaked in 2022 at $530 and has fallen 65.3% since, to $184 in 2023.
Across 73 payments — averaging $16.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$504
- Mayne Pharma Commercial LLC$94
- Agile Therapeutics, Inc.$92
- Exeltis, USA Inc.$57
- Organon$51
- Novo Nordisk$47
- plus $371 from 13 others
What the payments were for
- Food & beverage$1,18197%
- Gifts$363%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 34 | $504 |
| Mayne Pharma Commercial LLC | 4 | $94 |
| Agile Therapeutics, Inc. | 6 | $92 |
| Exeltis, USA Inc. | 3 | $57 |
| Organon | 2 | $51 |
| Novo Nordisk | 3 | $47 |
| Baxter Healthcare | 3 | $47 |
| Therapeuticsmd, Inc. | 3 | $45 |
| Myovant Sciences Inc. | 2 | $42 |
| Ascend Therapeutics US, LLC | 2 | $36 |
| Astellas Pharma US Inc | 2 | $32 |
| Scynexis, Inc. | 2 | $31 |
| Idorsia Pharmaceuticals US Inc | 1 | $25 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $24 |
| Exact Sciences | 1 | $22 |
| Evofem Biosciences, Inc. | 1 | $20 |
| Hologic Sales And Service, LLC | 1 | $19 |
| Virtus Pharmaceuticals LLC | 1 | $15 |
| Avion Pharmaceuticals | 1 | $14 |
How this compares
$1,218 in reported general payments places this provider in the 80th percentile of 609 women's health providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProgesteroneProgesterone, Micronized | 45 | $1,777 |
| Estradiol (Twice Weekly)Estradiol | 15 | $1,450 |
| Estradiol | 33 | $1,407 |
| Estradiol (Once Weekly)Estradiol | 11 | $254 |
| Levothyroxine Sodium | 29 | $144 |
Paid to pharmacies, not to this prescriber.
Other women's health in Grapevine
- Evelyn TingGrapevine$89K
- Ruth WhiddonGrapevine$4K
- Arden MoulinGrapevine$4K
- Samantha NealGrapevine$3K
- Christina TrumanWaco$70K
- Kayla CastanedaEl Paso$53K
- Shelagh LarsonFort Worth$43K
- Amanda ArmondAustin$17K
- Joann St PierreHouston$15K
- Christina BlancoEl Paso$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.